|
WO2008077810A2
(en)
|
2006-12-22 |
2008-07-03 |
F. Hoffmann-La Roche Ag |
Spiro-piperidine derivatives
|
|
AU2016200866B2
(en)
*
|
2007-03-12 |
2017-06-22 |
Glaxosmithkline Llc |
Phenyl amino pyrimidine compounds and uses thereof
|
|
EP3023422A1
(en)
|
2007-03-12 |
2016-05-25 |
YM BioSciences Australia Pty Ltd |
Phenyl amino pyrimidine compounds and uses thereof
|
|
AU2013201306B2
(en)
*
|
2007-03-12 |
2015-11-12 |
Glaxosmithkline Llc |
Phenyl Amino Pyrimidine Compounds and Uses Thereof
|
|
EP2137165B1
(en)
*
|
2007-04-24 |
2013-04-24 |
Ingenium Pharmaceuticals GmbH |
Inhibitors of protein kinases
|
|
ES2535166T3
(es)
|
2007-09-04 |
2015-05-06 |
The Scripps Research Institute |
Pirimidinil-aminas sustituidas como inhibidores de proteína-quinasas
|
|
ATE535515T1
(de)
|
2008-01-11 |
2011-12-15 |
Hoffmann La Roche |
Modulatoren für amyloid beta
|
|
EP2257541B1
(en)
*
|
2008-02-22 |
2013-08-14 |
F. Hoffmann-La Roche AG |
Modulators for amyloid beta
|
|
MX2011003246A
(es)
|
2008-10-09 |
2011-04-21 |
Hoffmann La Roche |
Moduladores de beta amiloide.
|
|
WO2010052199A1
(en)
|
2008-11-10 |
2010-05-14 |
F. Hoffmann-La Roche Ag |
Heterocyclic gamma secretase modulators
|
|
MX2012004313A
(es)
*
|
2009-10-12 |
2012-07-20 |
Myrexis Inc |
Compuestos de amino-pirimidina como inhibidores de cinasa 1 de union a tank (tbk1) y/o i-kappa-b-cinasa epsilon (ikk epsilon).
|
|
PE20121480A1
(es)
|
2009-12-17 |
2012-11-10 |
Merck Sharp & Dohme |
Aminopirimidinas como inhibidores de syk
|
|
WO2011075560A1
(en)
|
2009-12-17 |
2011-06-23 |
Merck Sharp & Dohme Corp. |
Aminopyrimidines as syk inhibitors
|
|
US8486967B2
(en)
|
2010-02-17 |
2013-07-16 |
Hoffmann-La Roche Inc. |
Heteroaryl substituted piperidines
|
|
CN104086528A
(zh)
|
2010-07-15 |
2014-10-08 |
拜耳知识产权有限责任公司 |
作为杀虫剂的新杂环化合物
|
|
GB201012105D0
(en)
|
2010-07-19 |
2010-09-01 |
Domainex Ltd |
Novel pyrimidine compounds
|
|
WO2012018639A2
(en)
|
2010-07-26 |
2012-02-09 |
Biomatrica, Inc. |
Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
|
|
US9376709B2
(en)
|
2010-07-26 |
2016-06-28 |
Biomatrica, Inc. |
Compositions for stabilizing DNA and RNA in blood and other biological samples during shipping and storage at ambient temperatures
|
|
CN103270029B
(zh)
*
|
2010-10-22 |
2016-01-20 |
拜耳知识产权有限责任公司 |
作为农药的杂环化合物
|
|
US8754114B2
(en)
|
2010-12-22 |
2014-06-17 |
Incyte Corporation |
Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
|
|
EP2681215B1
(en)
|
2011-02-28 |
2015-04-22 |
Array Biopharma, Inc. |
Serine/threonine kinase inhibitors
|
|
JP6147727B2
(ja)
|
2011-04-01 |
2017-06-14 |
ユニヴァーシティー オブ ユタ リサーチ ファウンデーション |
チロシン受容体キナーゼｂｔｋ阻害剤としての置換ｎ−（３−（ピリミジン−４−イル）フェニル）アクリルアミド類似体
|
|
KR20140048873A
(ko)
*
|
2011-04-12 |
2014-04-24 |
알츠하이머즈 인스티튜트 오브 아메리카, 인크. |
Ｉｋｋ－관련 키나제 엡실론 및 ｔａｎｋ 결합 키나제 1 억제제의 조성물 및 치료학적 용도
|
|
ES2613103T3
(es)
|
2011-04-19 |
2017-05-22 |
Bayer Intellectual Property Gmbh |
4-Aril-n-fenil-1,3,5-triacin-2-aminas sustituidas
|
|
JP2014513686A
(ja)
|
2011-05-10 |
2014-06-05 |
メルク・シャープ・アンド・ドーム・コーポレーション |
Ｓｙｋ阻害薬としてのアミノピリミジン
|
|
WO2012154520A1
(en)
|
2011-05-10 |
2012-11-15 |
Merck Sharp & Dohme Corp. |
Pyridyl aminopyridines as syk inhibitors
|
|
EP2706852B1
(en)
|
2011-05-10 |
2018-08-22 |
Merck Sharp & Dohme Corp. |
Bipyridylaminopyridines as syk inhibitors
|
|
TW201636330A
(zh)
|
2011-05-24 |
2016-10-16 |
拜耳知識產權公司 |
含有硫醯亞胺基團之４－芳基－ｎ－苯基－１，３，５－三氮雜苯－２－胺
|
|
JP5977348B2
(ja)
*
|
2011-07-12 |
2016-08-24 |
ダウ アグロサイエンシィズ エルエルシー |
殺有害生物剤組成物およびこれに関連した方法
|
|
EP2739618B1
(en)
|
2011-08-04 |
2015-09-16 |
Array Biopharma, Inc. |
Quinazoline compounds as serine/threonine kinase inhibitors
|
|
DE102011112978A1
(de)
|
2011-09-09 |
2013-03-14 |
Merck Patent Gmbh |
Benzonitrilderivate
|
|
WO2013037894A1
(en)
|
2011-09-16 |
2013-03-21 |
Bayer Intellectual Property Gmbh |
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group
|
|
ES2587284T3
(es)
|
2011-09-16 |
2016-10-21 |
Bayer Intellectual Property Gmbh |
5-Fluoro-pirimidinas 2,4-disustituidas como inhibidores selectivos de CDK9
|
|
MY191936A
(en)
|
2012-03-01 |
2022-07-19 |
Genentech Inc |
Serine/threonine kinase inhibitors
|
|
CN107652289B
(zh)
|
2012-06-13 |
2020-07-21 |
因塞特控股公司 |
作为fgfr抑制剂的取代的三环化合物
|
|
US8809359B2
(en)
|
2012-06-29 |
2014-08-19 |
Ym Biosciences Australia Pty Ltd |
Phenyl amino pyrimidine bicyclic compounds and uses thereof
|
|
US9388185B2
(en)
|
2012-08-10 |
2016-07-12 |
Incyte Holdings Corporation |
Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
|
|
EP2888247B1
(en)
|
2012-08-27 |
2020-03-25 |
Array Biopharma, Inc. |
Serine/threonine kinase inhibitors for the treatment of hyperproliferative diseases
|
|
WO2014055934A2
(en)
*
|
2012-10-04 |
2014-04-10 |
University Of Utah Research Foundation |
Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors
|
|
CN104822664B
(zh)
|
2012-10-04 |
2017-01-18 |
犹他大学研究基金会 |
作为酪氨酸受体激酶btk抑制剂的取代的n‑(3‑(嘧啶‑4‑基)苯基)丙烯酰胺类似物
|
|
ES2597232T3
(es)
|
2012-10-18 |
2017-01-17 |
Bayer Pharma Aktiengesellschaft |
4-(orto)-fluorofenil-5-fluoropirimidin-2-il aminas que contienen un grupo sulfona
|
|
CN104854091B
(zh)
|
2012-10-18 |
2018-04-03 |
拜耳药业股份公司 |
含砜基团的5‑氟‑n‑(吡啶‑2‑基)吡啶‑2‑胺衍生物
|
|
TW201418243A
(zh)
|
2012-11-15 |
2014-05-16 |
Bayer Pharma AG |
含有磺醯亞胺基團之ｎ－（吡啶－２－基）嘧啶－４－胺衍生物
|
|
US9266892B2
(en)
|
2012-12-19 |
2016-02-23 |
Incyte Holdings Corporation |
Fused pyrazoles as FGFR inhibitors
|
|
WO2014100755A2
(en)
|
2012-12-20 |
2014-06-26 |
Biomatrica, Inc. |
Formulations and methods for stabilizing pcr reagents
|
|
GB201303109D0
(en)
|
2013-02-21 |
2013-04-10 |
Domainex Ltd |
Novel pyrimidine compounds
|
|
JP6449244B2
(ja)
|
2013-04-19 |
2019-01-09 |
インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ |
Ｆｇｆｒ抑制剤としての二環式複素環
|
|
CA2915250A1
(en)
|
2013-06-13 |
2015-01-08 |
Biomatrica, Inc. |
Cell stabilization
|
|
EP3942931A1
(en)
|
2014-06-10 |
2022-01-26 |
Biomatrica, INC. |
Stabilization of thrombocytes at ambient temperatures
|
|
TWI681954B
(zh)
|
2014-06-12 |
2020-01-11 |
美商西爾拉癌症醫學公司 |
Ｎ-（氰基甲基）-４-（２-（４-𠰌啉基苯基胺基）嘧啶-４-基）苯甲醯胺
|
|
WO2016059011A1
(en)
|
2014-10-16 |
2016-04-21 |
Bayer Pharma Aktiengesellschaft |
Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfone group
|
|
US10851105B2
(en)
|
2014-10-22 |
2020-12-01 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
|
ES2751669T3
(es)
|
2015-02-20 |
2020-04-01 |
Incyte Corp |
Heterociclos bicíclicos como inhibidores FGFR
|
|
WO2016134294A1
(en)
|
2015-02-20 |
2016-08-25 |
Incyte Corporation |
Bicyclic heterocycles as fgfr4 inhibitors
|
|
MA41551A
(fr)
|
2015-02-20 |
2017-12-26 |
Incyte Corp |
Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
|
|
WO2016150902A1
(en)
|
2015-03-24 |
2016-09-29 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating gastric cancers
|
|
WO2016150903A1
(en)
|
2015-03-24 |
2016-09-29 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating lymphomas
|
|
EP3274338A1
(en)
|
2015-03-24 |
2018-01-31 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating multiple myeloma
|
|
HRP20211864T1
(hr)
|
2015-07-06 |
2022-03-04 |
Alkermes, Inc. |
Inhibitori hetero-halo histonske deacetilaze
|
|
US10421756B2
(en)
|
2015-07-06 |
2019-09-24 |
Rodin Therapeutics, Inc. |
Heterobicyclic N-aminophenyl-amides as inhibitors of histone deacetylase
|
|
CN108290903B
(zh)
|
2015-09-29 |
2021-09-03 |
拜耳医药股份有限公司 |
新的大环磺酰二亚胺化合物
|
|
US10214542B2
(en)
|
2015-10-08 |
2019-02-26 |
Bayer Pharma Aktiengesellschaft |
Modified macrocyclic compounds
|
|
WO2017060322A2
(en)
|
2015-10-10 |
2017-04-13 |
Bayer Pharma Aktiengesellschaft |
Ptefb-inhibitor-adc
|
|
MY196174A
(en)
|
2015-10-12 |
2023-03-20 |
Chong Kun Dang Pharmaceutical Corp |
Oxadiazole Amine Derivative Compounds as Histone Deacetylase 6 Inhibitor, and the Pharmaceutical Composition Comprising the Same
|
|
ES3037826T3
(en)
|
2015-12-08 |
2025-10-07 |
Biomatrica Inc |
Reduction of erythrocyte sedimentation rate
|
|
JP6740452B2
(ja)
*
|
2016-07-26 |
2020-08-12 |
深▲セン▼市塔吉瑞生物医▲薬▼有限公司Ｓｈｅｎｚｈｅｎ ＴａｒｇｅｔＲｘ，Ｉｎｃ． |
プロテインチロシンキナーゼの活性を阻害するためのアミノピリミジン系化合物
|
|
EP3509586A4
(en)
*
|
2016-09-12 |
2020-05-06 |
Imago Pharmaceuticals, Inc. |
TREATMENT OF FIBROTIC DISORDERS WITH JUN N-TERMINAL KINASE INHIBITORS
|
|
HRP20220223T1
(hr)
|
2017-01-11 |
2022-04-29 |
Alkermes, Inc. |
Biciklički inhibitori histon deacetilaze
|
|
US20190381125A1
(en)
*
|
2017-02-15 |
2019-12-19 |
University Of Massachusetts |
Methods of Treating Angiogenesis-Related Disorders Using JNK3 Inhibitors
|
|
GB201702947D0
(en)
|
2017-02-23 |
2017-04-12 |
Domainex Ltd |
Novel compounds
|
|
EP3601236A1
(en)
|
2017-03-28 |
2020-02-05 |
Bayer Aktiengesellschaft |
Novel ptefb inhibiting macrocyclic compounds
|
|
ES2900199T3
(es)
|
2017-03-28 |
2022-03-16 |
Bayer Ag |
Novedosos compuestos macrocíclicos inhibidores de PTEFB
|
|
GB201705263D0
(en)
*
|
2017-03-31 |
2017-05-17 |
Probiodrug Ag |
Novel inhibitors
|
|
AR111960A1
(es)
|
2017-05-26 |
2019-09-04 |
Incyte Corp |
Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
|
|
PL3664802T3
(pl)
|
2017-08-07 |
2022-07-11 |
Alkermes, Inc. |
Bicykliczne inhibitory deacetylaz histonowych
|
|
EP3697772A1
(en)
*
|
2017-10-17 |
2020-08-26 |
Merck Patent GmbH |
Pyrimidine tbk/ikk inhibitor compounds and uses thereof
|
|
KR20200071756A
(ko)
*
|
2017-10-17 |
2020-06-19 |
메르크 파텐트 게엠베하 |
피리미딘 TBK/IKKε 억제제 화합물 및 이의 용도
|
|
JP7416716B2
(ja)
|
2017-12-28 |
2024-01-17 |
トラクト ファーマシューティカルズ インコーポレイテッド |
円柱上皮幹細胞のための幹細胞培養系およびそれに関連した使用法
|
|
MA51820A
(fr)
|
2018-02-13 |
2021-05-19 |
Bayer Ag |
Utilisation de 5-fluoro-4-(4-fluoro-2-méthoxyphényl)-n-(4-[(s-méthylsulfonimidoyl)méthyl]pyridin-2-yl)pyridin-2-amine pour traiter un lymphome diffus à grandes cellules b
|
|
PE20210919A1
(es)
|
2018-05-04 |
2021-05-19 |
Incyte Corp |
Sales de un inhibidor de fgfr
|
|
CN119241541A
(zh)
|
2018-05-04 |
2025-01-03 |
因赛特公司 |
Fgfr抑制剂的固体形式和其制备方法
|
|
WO2020068846A1
(en)
*
|
2018-09-25 |
2020-04-02 |
Heterocyclic Compound |
Heterocyclic compound
|
|
TWI850262B
(zh)
*
|
2018-09-25 |
2024-08-01 |
美商卡都瑞恩醫藥公司 |
胺基嘧啶化合物
|
|
CA3124324A1
(en)
*
|
2018-12-21 |
2020-06-25 |
Bayer Aktiengesellschaft |
1,3,4-oxadiazoles and their derivatives as new antifungal agents
|
|
WO2020185532A1
(en)
|
2019-03-08 |
2020-09-17 |
Incyte Corporation |
Methods of treating cancer with an fgfr inhibitor
|
|
US11591329B2
(en)
|
2019-07-09 |
2023-02-28 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
EP4027993A4
(en)
*
|
2019-09-13 |
2023-09-20 |
The Broad Institute Inc. |
CYCLO-OXYGENASE 2 INHIBITORS AND THEIR USES
|
|
WO2021067374A1
(en)
|
2019-10-01 |
2021-04-08 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
|
GEP20247679B
(en)
|
2019-10-14 |
2024-10-10 |
Incyte Corp |
Bicyclic heterocycles as fgfr inhibitors
|
|
US11566028B2
(en)
|
2019-10-16 |
2023-01-31 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
CA3163875A1
(en)
|
2019-12-04 |
2021-06-10 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
|
IL293001A
(en)
|
2019-12-04 |
2022-07-01 |
Incyte Corp |
Derivatives of fgfr repressors
|
|
US12012409B2
(en)
|
2020-01-15 |
2024-06-18 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
JP7587113B2
(ja)
*
|
2020-09-29 |
2024-11-20 |
日亜化学工業株式会社 |
異方性磁性粉末の製造方法および異方性磁性粉末
|
|
JP2024513575A
(ja)
|
2021-04-12 |
2024-03-26 |
インサイト・コーポレイション |
Ｆｇｆｒ阻害剤及びネクチン－４標的化剤を含む併用療法
|
|
WO2022261160A1
(en)
|
2021-06-09 |
2022-12-15 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
|
AR126101A1
(es)
|
2021-06-09 |
2023-09-13 |
Incyte Corp |
Heterociclos tricíclicos como inhibidores de fgfr
|
|
WO2023107705A1
(en)
|
2021-12-10 |
2023-06-15 |
Incyte Corporation |
Bicyclic amines as cdk12 inhibitors
|